Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple multivitamin boost birth weights in bangladesh?

NCT ID NCT07540130

Disease control Sponsor: National Institute of Neurosciences and Hospital, Dhaka Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a daily multiple micronutrient supplement (MMS) to the standard iron-folic acid supplement in 667 pregnant women in Bangladesh. The main goal is to see if MMS leads to higher infant birth weight. Researchers will also check maternal health, preterm birth rates, and how well women stick to the supplements. Results could help improve nutrition programs for pregnant women in low-resource settings.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
multiple micronutrient supplement (UNIMMAP) vs iron-folic acid
What this could lead to
If successful, this could show that a simple daily supplement with multiple vitamins and minerals is better than iron-folic acid alone for improving birth weight and reducing complications in pregnant women.
What could go wrong
This is an early-phase study in a specific region, so results may not apply elsewhere. The supplements are already known to be safe, but the real-world setting may affect adherence and outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1/2

Runs two stages together: safety and dose first, then whether the treatment works.

Participants

667 people

The number who actually took part.

Started

Feb 2025

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 35 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants will be eligible if they meet all of the following: 1. Confirmed pregnancy, preferably in the first trimester, with singleton pregnancy where feasible. 2. Permanent residence within the selected study catchment areas and ability to remain in the study area throughout follow-up. 3. Enrollment in IPHN-supported antenatal care or supplementation programs. 4. Nutritional vulnerability identified through screening indicators (eg, MUAC, BMI, or hemoglobin). 5. Willingness to receive MMS or IFAS supplementation as assigned by routine service delivery platforms. 6. Provision of written informed consent (thumbprint with witness for illiterate participants). 7. Planned facility-based delivery or verifiable delivery location. Exclusion Criteria: * Participants will be excluded if any of the following apply: 1. Withdrawal of informed consent at any stage. 2. Diagnosed chronic medical conditions likely to influence pregnancy outcomes or nutritional biomarkers (eg, diabetes, hypertension, thyroid disorders, thalassemia). 3. Planned relocation outside the study area before completion of follow-up. 4. High-risk pregnancy requiring specialized tertiary care at enrollment. 5. Participation in another nutrition intervention or clinical trial during the study period. 6. Multiple gestation pregnancies (eg, twins).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnant women are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pregnant women Pregnant women and their offspring

Contacts and locations

Locations

  • National Institute of Neurosciences & Hospital Dhaka, Bangladesh

    Dhaka, Dhaka Division, 1207, Bangladesh

More trials for these conditions

Other studies related to the condition(s) this trial covers.